THE BOYER COMPANYBoyer Company • July 5th, 2005 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
This letter is written to memorialize our agreement regarding the payment of base rent as a product of the rate of return multiplied by the final construction costs once they are determined for Phase IV for purposes of the Lease Agreement, Research Park – Phase IV, by and between BOYER RESEARCH PARK ASSOCIATES VIII BY ITS GENERAL PARTNER, THE BOYER COMPANY, L.C. and MYRIAD GENETICS, INC., dated May 31, 2005 (the “Lease”). Capitalized terms used herein shall have the meanings ascribed to such capitalized terms in the Lease.
